How to create value-based healthcare for the future Medical
People are becoming more proactive in managing their health and they expect — rightly so — continuous access to high-quality care and an increasing range of medical innovations. As a result, healthcare systems around the world are struggling with rising costs and patient discontent. A “business as usual” approach no longer counts as a plan in healthcare.
“Patients want to be more involved in their health and are engaging in their healthcare in new ways, empowered by innovative digital technologies.” — Jørgen Behrens from Philips
However, the patients’ new assertiveness could form part of a new, value-based strategy for healthcare in the 21st century. Digital technology can empower people to manage their own healthcare, while also giving health providers tools to improve care in the form of data on the outcomes of treatments. Digitally-empowered integrated health systems can allow people and doctors to work closer together for continuous care between hospital and home. In turn, this can maximize value for patients, be achieving the best outcomes at the lowest cost.
“Patients want to be more involved in their health and are engaging in their healthcare in new ways, empowered by innovative digital technologies,” said Jørgen Behrens, senior vice president and business leader for personal health solutions at Philips. “We see many differences in how systems are transitioning to value-based care — it is happening everywhere.”
Value-based care means a new way of steering healthcare systems. Instead of traditional inputs, such as physician visits, hospitalizations, and procedures, the key information will be the outcomes and patient needs. The new thinking needs to be reflected in policies and practices at all levels of health care: performance indicators, tenders, reimbursement schemes, health budgets and innovation funds.
“We are disinvesting in things that don’t work,” said Luke Slawomirski, health economist and policy analyst in the health division of the Organisation for Economic Co-operation and Development. “This creates the fiscal space for things that we want and incentivizes the manufacturers of these technologies to invest. The beauty of value-based pricing is that it is an automatic stabilizer for things we should be doing more of and things that are not producing the expected benefits.”
Outcome-based healthcare has already made some progress. The United States has implemented a number of government-run value-based programs that reward healthcare providers with incentive payments for the quality of care. Singapore has created a system for the compulsory reporting of health outcome data for patients suffering from cancer, renal failure, stroke, acute myocardial infarction and other diseases.
“The beauty of value-based pricing is that it is an automatic stabilizer for things we should be doing more of and things that are not producing the expected benefits. ” — Luke Slawomirski, from the OECD
Europe needs to first ensure that its health technology assessment (HTA) evaluation methods accurately reflect the medical technologies they are measuring. HTA criteria for medical devices need to answer questions in different categories, such as prevention, screening, and diagnostics. They also need to address problems, such as the justification for purchasing technologies, whose outcomes are proven over time and have not yet been established. Only then will HTA accelerate the move to value-based care.
“We are trying to measure outcomes on quality of life,” said Wim Goettsch, director, EUnetHTA JA3 Directorate. “We all have the idea that we should use the same, evidence-based technology assessment so that this can be done at a European level. But member states decide what treatments to reimburse, depending on what people are prepared to pay for. Therefore, clinical appraisals should be done by national health systems.”
Changes in policy are eventually reflected in changes in procurement, according to Yves Verhoeven, director for market access & economic policies at MedTech Europe. “We consider it critical to move from price-based procurement to more value-based procurement and look at the absolute benefits that are being obtained,” he said. “We have to prioritize and see what is bringing the most value.”
“In the past, it was OK to ask patient questions, but patients were not really listened to in the doctor’s office. Now it is a dialogue.” — Andrzej Rys from DG SANTE at the European Commission
Connected health solutions provide a wealth of opportunities for collaboration between multidisciplinary care providers and their patients across the entire health continuum. This will, ultimately, transform healthcare from a supply-driven model into a patient-centric and integrated delivery model — something that people will experience during interactions with their doctors.
Andrzej Rys, who started out as a doctor 30 years ago and is now director for health systems, medical products, and innovation at DG SANTE in the European Commission, said: “One of the major changes is the consumer and patient voice in the system. In the past, it was OK to ask a patient question, but patients were not really listened to in the doctor’s office. Now it is a dialogue.”
That dialogue — plus partnerships between industry, hospitals, and governments — will be vital to make value-based healthcare a success.
Courtesy: By Philips, Source link